NFKB1 and triple-negative breast carcinoma: In summary, we characterized eugenol administration significantly inhibiting the proliferation and metastasis of triple-negative breast cancer cells, mechanistically, our data highlighted eugenol could play an anti-tumor role by inhibiting NOD1-NF-κB signal pathway.